• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Race for Adam

  • Meet Adam
  • What We Do
    • Mission & Goals
    • What is Niemann Pick Type C
    • NPC In The News
  • Events
    • 10th Drive For Adam
    • Sponsorship Request
  • Get Involved
  • Contact Us

NPC In The News

Niemann-Pick Disease

September 13, 2011
E.R. physician Dr. Travis Stork explains how Niemann-Pick disease affects the body.
Watch Video 

TRND Research Leads to NIH Trial to Test Drug for Niemann-Pick Type C1

Today, a promising new treatment is on the horizon. On Jan. 23, 2013, NIH initiated a Phase I clinical trial to evaluate the safety and effectiveness of cyclodextrin as a potential therapy for Niemann-Pick type C1.

This progress is the result of the collaborative efforts of an award-winning, multidisciplinary team of experts from NCATS, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Human Genome Research Institute; Janssen Research & Development, LLC; Washington University in St. Louis School of Medicine; Albert Einstein School of Medicine, New York City; and University of Pennsylvania, Philadelphia.

Read More 

Niemann-Pick Disease Type C (NPC) – Epidemiology Forecast to 2027

Report Scope:
The report covers detailed overview of Niemann-Pick Disease Type C (NPC) explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns The report provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan The Report assesses the disease risk and burden and highlights the unmet needs of Niemann-Pick Disease Type C (NPC) The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population The report provides the segmentation of the disease epidemiology by total prevalent patient population, diagnosed population, sub-types and clinical distribution in 7MM
 
Read the report 
Tweet
Pin
Share
0 Shares

sidebar

Page Sidebar

TwitterFacebookPinterestYoutube
You Can Help Make a DifferenceJOIN US

Join our Mailing List

  • This field is for validation purposes and should be left unchanged.

Interested in Donating?

There are so many great ways to get involved. Volunteer your time or simply provide a financial donation. Every dollar makes a difference.
DONATE

Contact Information

Race for Adam Foundation

4415 Pheasant Run Court

Bethlehem, PA 18020

  • Meet Adam
  • What We Do
  • Contact Us


Copyright © 2025
Site Developed & Maintained by: KLK Web Services, LLC